StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.09 (+6.29%)

Close on Nov 17, 2026Market cap $72.03MP/E –Yield –

Zhengye Biotechnology cash

Cash and short-term investments held at the end of each period.

Zhengye Biotechnology's cash was CN¥51.89M at Dec 31, 2025. For fiscal 2025 it was CN¥51.89M, up 159.0% from the year before. The highest annual figure on record is CN¥51.89M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥51.89M+159.0%
FY2024Dec 31, 2024CN¥20.04M-29.5%
FY2023Dec 31, 2023CN¥28.41M+191.5%
FY2022Dec 31, 2022CN¥9.75M+55.1%
FY2021Dec 31, 2021CN¥6.28M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025CN¥51.89M+82.7%
Q2 FY2025Jun 30, 2025CN¥47.63M+388.7%
Q4 FY2024Dec 31, 2024CN¥20.04M+218.9%
Q2 FY2024Jun 30, 2024CN¥7.19M–
Q4 FY2023Dec 31, 2023CN¥28.41M–
Q4 FY2022Dec 31, 2022CN¥9.75M–
Q4 FY2021Dec 31, 2021CN¥6.28M–

More Zhengye Biotechnology figures

See a number that looks wrong?